公开(公告)号：US12098146B2

公开(公告)日：2024-09-24

申请号：US16751803

申请日：2020-01-24

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： Iwona Wrona ,  Kerem Ozboya ,  Matthew Lucas ,  Bhaumik Pandya ,  Bertrand Le Bourdonnec

IPC: C07D413/04 ,  A61K31/166 ,  A61K31/175 ,  A61K31/436 ,  A61K31/4439 ,  A61K31/453 ,  A61K31/4545 ,  A61K31/475 ,  A61K31/495 ,  A61K31/497 ,  A61K31/501 ,  A61K31/55 ,  A61K45/06 ,  A61P35/00 ,  A61P35/04 ,  C07D237/22 ,  C07D401/06 ,  C07D401/12 ,  C07D403/12 ,  C07D413/14 ,  C07D417/14

CPC classification number: C07D413/14 ,  A61P35/04 ,  C07D401/06 ,  C07D401/12 ,  C07D403/12 ,  C07D413/04 ,  C07D417/14 ,  A61K31/495

Abstract: The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.

公开(公告)号：US12180221B2

公开(公告)日：2024-12-31

申请号：US17028778

申请日：2020-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： Bertrand Le Bourdonnec ,  Matthew Lucas ,  Kerem Ozboya ,  Bhaumik Pandya ,  Parcharee Tivitmahaisoon ,  Iwona Wrona

IPC: C07D491/107 ,  C07D213/82 ,  C07D237/04 ,  C07D237/24 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/14 ,  C07D409/14 ,  C07D413/12 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04 ,  C07D513/04

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

公开(公告)号：US11873298B2

公开(公告)日：2024-01-16

申请号：US16758495

申请日：2018-10-24

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： Matthew Lucas ,  Bertrand Le Bourdonnec ,  Iwona Wrona ,  Bhaumik Pandya ,  Parcharee Tivitmahaisoon ,  Kerem Ozboya ,  Benjamin Vincent ,  Daniel Tardiff ,  Jeff Piotrowski ,  Eric Solis ,  Robert Scannevin ,  Chee-Yeun Chung ,  Rebecca Aron ,  Kenneth Rhodes

IPC: C07D413/14 ,  C07D271/07 ,  C07D413/04 ,  C07D413/10 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D487/10

CPC classification number: C07D413/14 ,  C07D271/07 ,  C07D413/04 ,  C07D413/10 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D487/10

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

公开(公告)号：US11970486B2

公开(公告)日：2024-04-30

申请号：US16344195

申请日：2017-10-24

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： Bertrand Le Bourdonnec ,  Matthew Lucas ,  Kerem Ozboya ,  Bhaumik Pandya ,  Parcharee Tivitmahaisoon ,  Iwona Wrona

IPC: C07D413/14 ,  C07D413/04 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04

CPC classification number: C07D413/14 ,  C07D413/04 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

公开(公告)号：US20240124435A1

公开(公告)日：2024-04-18

申请号：US18373702

申请日：2023-09-27

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： Matthew Lucas ,  Bertrand Le Bourdonnec ,  Iwona Wrona ,  Bhaumik Pandya ,  Parcharee Tivitmahaisoon ,  Kerem Ozboya ,  Benjamin Vincent ,  Daniel Tardiff ,  Jeff Piotrowski ,  Eric Solis ,  Robert Scannevin ,  Chee-Yeun Chung ,  Rebecca Aron ,  Kenneth Rhodes

IPC: C07D413/14 ,  C07D271/07 ,  C07D413/04 ,  C07D413/10 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D487/10

CPC classification number: C07D413/14 ,  C07D271/07 ,  C07D413/04 ,  C07D413/10 ,  C07D417/04 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D487/10

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.